News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ipsen (IPN.PA): Sales in the Third Quarter and First Nine Months of 2013


10/30/2013 7:18:31 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and 

post your resume.

Regulatory News:

Commenting on the first nine months of 2013, Marc de Garidel, Chairman and Chief Executive Officer of Ipsen, said: “Over the first 9 months of the year, Somatuline® and Dysport® have continued to post solid growths of respectively 12.0%1 and 6.8%1.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Ipsen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES